Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale

Enzon Pharma (ENZN) to Trim Workforce by About Half

December 20, 2012 5:13 PM EST

On December 17, 2012, Enzon Pharmaceuticals, Inc. (the Company) issued a press release announcing that its Board of Directors (the Board) has retained Lazard to act as a financial advisor in a review of the possible sale or disposition of one or more corporate assets, or a sale of the Company. The Company... More